UrSure makes urine tests to help doctors and patients improve medication adherence. We are initially focused on drugs to prevent and treat HIV infections. We have received over $2M in funding including winning the Harvard Business School's New Venture Competition and the Harvard President's Innovation Challenge as well as a Phase I and II SBIR from the NIH. We are currently working to scale up our lab based test, which is commercialized and on the market while we complete development of our Point of Care test which will be ready for use in research studies in 2019.
View Top Employees from UrSure, Inc.| Website | http://www.ursureinc.com |
| Revenue | $4 million |
| Employees | 3 (0 on RocketReach) |
| Founded | 2015 |
| Address | 127 Western Ave, Boston, Massachusetts 02134, US |
| Phone | (252) 287-8215 |
| Technologies |
JavaScript,
HTML,
Twitter
+11 more
(view full list)
|
| Industry | Medical Equipment Manufacturing, Chemicals, Petrochemicals, Glass & Gases, Health Care, Healthcare, Manufacturing, Medical, Medical Devices, Medical Device, Social Impact, Personal Health, HIV |
| Competitors | CGeneTech Inc, iReminder |
| SIC | SIC Code 28 Companies, SIC Code 281 Companies |
| NAICS | NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 32518 Companies, NAICS Code 325180 Companies, NAICS Code 3251 Companies |
Looking for a particular UrSure, Inc. employee's phone or email?
UrSure, Inc. Questions
The UrSure, Inc. annual revenue was $4 million in 2024.
UrSure, Inc. is based in Boston, Massachusetts.
The NAICS codes for UrSure, Inc. are [32, 325, 32518, 325180, 3251].
The SIC codes for UrSure, Inc. are [28, 281].
Related Companies
